Skip to content
★ Sign in to follow
Celltrion, Inc. logo

Celltrion, Inc. Stock: price and insider trades · South Korea

셀트리온

KR·Mcap ₩43.7THealth Care

No insider purchase over the last 90 days. The latest, by 셀트리온홀딩스, was filed 16 Jul 2026.

Insider Decl.
489
Thresholds
n/a
Buy Volume
€6B
219 ops. · all time
Sell Volume
€99M
61 ops. · all time

Who traded when

BuySale
셀트리온홀딩스30 buys4 sales
셀트리온스킨큐어9 buys
백경민5 buys
이응섭4 buys1 sale
박상준4 buys
신민철4 buys

+57 other insiders

Since the insiders bought

  • Filed 16 Jul 2026 · 116 days ago · €15.1M
    +11.0%
    Entry ₩172,600 · Close 30 Oct 2026 ₩191,600
  • Filed 03 Jul 2026 · 129 days ago · €26k
    +8.9%
    Entry ₩175,900 · Close 30 Oct 2026 ₩191,600
  • Filed 03 Jul 2026 · 129 days ago · €72k
    +8.9%
    Entry ₩175,900 · Close 30 Oct 2026 ₩191,600

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Analyst consensus: bullish or bearish?

Analysts rate Celltrion, Inc. Buy (bullish), based on 22 analysts. Average price target: ₩270,667.

Fundamental score
Ranked 14,283 of 26,913 companies
49.8
score / 100
Value
32
Quality
68
FCF yld0.7%
Earn yld2.1%
EV/EBITDA34.2x
ROE9.1%
Gross mgn59%
Net mgn25%
Debt/EBITDA2.5x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩191,600
Analyst consensus
22 analysts
Buy
₩200,000Target ₩270,667(+41%)₩310,000
Income statement
Revenue₩4.2T
Gross profit₩2.5T59% margin
EBITDA₩1.5T36% margin
Net income₩1T32.2% margin
Valuation
PER (forward)24.9x
Beta0.28
Balance sheet & cash
Market cap₩43.7T
Total debt₩3.7T
Free Cash Flow₩314.3B
Debt / Equity21%
Profitability & ownership
ROE9.1%
ROA4.4%
% insiders36.4%
% institutions21.5%
Last declaration on 16 July 2026
Declarations505 total
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • ▲
    Related company / holdingExecutives(filed)
    €15.1Mest.0DART
    148,258 sharesKRXDART:20260716000781
    Canonical exit: 14 Oct 2026 (T+90)
  • ▲
    Related company / holdingExecutives(filed)
    €8.8Mest.0DART
    84,865 sharesShareKRXDART:20260710000573
    Canonical exit: 8 Oct 2026 (T+90)
  • ▲
    Related company / holdingExecutives(filed)
    €30.0Mest.0DART
    300,000 sharesShareKRXDART:20260707000380
    Canonical exit: 5 Oct 2026 (T+90)
  • ▲
    상무Executives(filed)
    €26kest.0DART
    249 sharesShareKRXDART:20260703000363
    Canonical exit: 1 Oct 2026 (T+90)
  • ▲
    상무Executives(filed)
    €72kest.0DART
    687 sharesShareKRXDART:20260703000399
    Canonical exit: 1 Oct 2026 (T+90)
  • ▲
    상무Executives(filed)
    €27kest.0DART
    259 sharesShareKRXDART:20260703000433
    Canonical exit: 1 Oct 2026 (T+90)
  • ▲
    이사Executives(filed)
    €9,376est.0DART
    90 sharesShareKRXDART:20260703000353
    Canonical exit: 1 Oct 2026 (T+90)
  • ▲
    이사Executives(filed)
    €12kest.0DART
    115 sharesShareKRXDART:20260703000373
    Canonical exit: 1 Oct 2026 (T+90)
  • ▲
    이사Executives(filed)
    €41kest.0DART
    396 sharesShareKRXDART:20260703000377
    Canonical exit: 1 Oct 2026 (T+90)

25 of 505 declarations

About Celltrion, Inc.

Trades by 셀트리온홀딩스 (filed as 대량보유자) dominate the 셀트리온 (Celltrion, Inc.) record: a sale of EUR 66,833,193 on April 15, 2026 and a purchase of EUR 15,774,804 on February 26, 2026. 셀트리온스킨큐어 (사실상지배주주) bought EUR 7,007,058 on June 25, 2025, then EUR 6,187,200 on July 3, 2025.

In all, the record holds 219 purchases (17 with an amount, EUR 30.9 million, median EUR 114,115) and 61 sales (8 with an amount, EUR 68.7 million, median EUR 323,042), or 78% purchases among open-market trades. 209 filings are of another kind. The most frequent filer is 하태훈 (이사) with 193 filings, one of them a sale.

Read moreShow less

A South Korean company in the Health Care sector, listed on Korea Exchange and valued at KRW 44.8 trillion, Celltrion, Inc. has 489 filings from 74 filers between February 17, 2021 and July 16, 2026; insiders hold 36.3% of the capital. Between June 29 and July 16, 2026, 56 filers bought. The last twelve months hold 111 filings, of which 95 purchases and 11 sales. For 106 purchases a 90-day result is stored: a median of 3.8%, with 80% of results positive, recorded past results, not a forecast.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations